TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT05889793

Evaluating Emetine for Viral Outbreaks (EVOLVE)

Cause of deathSlow enrollment, also staffing, sites or logistics Automatic label, confidence 0.5, unverified. How labels are made.
“The study was terminated due to insufficient participant enrollment resulting from a lower-than-expected number of COVID-19 cases”

The sponsor’s own words in the registry.

Life of this trial

2023202420252026Registered2023-05-23Started2024-05-15Stopped2025-12-15

Vital statistics

Status
Terminated
Phase
Phase 2, Phase 3
Sponsor
Johns Hopkins University
Sponsor type
University, hospital or other
Conditions
COVID-19
Interventions
Emetine Hydrochloride; Placebo
Participants
4
Sites
2
Countries
Nepal, United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.